| # | Drug | Count |
|---|---|---|
| 0 | ALEMTUZUMAB | 4 |
| 1 | ACETAMINOPHEN | 3 |
| 2 | DIPHENHYDRAMINE HYDROCHLORIDE | 3 |
| 3 | FLUOXETINE HYDROCHLORIDE | 3 |
| 4 | RANITIDINE | 3 |
| 5 | ACETAMINOPHEN 500MG | 2 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 2 |
| 7 | ACYCLOVIR | 2 |
| 8 | BACLOFEN | 2 |
| 9 | DIPHENHYDRAMINE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MAGNESIUM SALICYLATE | 1 | 0.0017 |
| 1 | ALBENDAZOLE | 1 | 0.0005 |
| 2 | DHEA (DEHYDROEPIANDROSTERONE) | 1 | 0.0005 |
| 3 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 4 | SELENIUM | 1 | 0.0002 |
| 5 | ALEMTUZUMAB | 4 | 0.0002 |
| 6 | POTASSIUM CITRATE | 1 | 0.0002 |
| 7 | ETODOLAC | 1 | 0.0002 |
| 8 | AMISULPRIDE | 1 | 0.0002 |
| 9 | SPARSENTAN | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 1 | 0.0003 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 2 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 5 | Bile Acid [EPC] | 1 | 0.0000 |
| 6 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 7 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 8 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 2 | 0.0000 |
| 9 | Central alpha-2 Adrenergic Agonist [EPC] | 1 | 0.0000 |